Local view for "http://purl.org/linkedpolitics/eu/plenary/2007-06-19-Speech-2-393"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20070619.44.2-393"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spoken text |
".
One of the problems is that we do not have sufficient statistics on this issue. But we know from the evidence we have in front of us is that it is at least 1% of healthcare, so this will increase expectations. The main reason so far is the issue of the lack of information. People are not aware they have this right, and the more they become aware of this the more they will seek treatment abroad. This is an opportunity for us to regulate before it becomes too big an issue, before it is too late.
I am afraid I do not have any indication of the complaints from people not being granted authorisation. As you know, we have had cases before the European Court of Justice where citizens were dissatisfied with a negative decision but, at the same time, the patients’ lack of knowledge that they can seek redress at European level does not give us an accurate and clear picture either. That is why, when I was answering you question earlier, I only had in front of me the collection of data and cross-border health service which will be one of the priorities of the upcoming initiative."@en1
|
| lpv:unclassifiedMetadata |
Named graphs describing this resource:
The resource appears as object in 2 triples